President and CEO: Troy Wilson.

Financial information: Company has raised $41 million from investors.

No. of local employees: 36.

Investors: Sofinnova Ventures, CMEA Capital, Novartis Venture Funds, Abingworth, U.S. Venture Partners, FinTech Global Capital and Biogen Idec.

Headquarters: La Jolla.

Year founded: 2007.

Company description: A clinical-stage pharmaceutical biotech company discovering and developing small molecule drugs that treat cancer and other diseases.

Key factors for success: The company is focused on phosphoinositide 3-kinase inhibitors, or PI3K inhibitors, which are a hot target among major pharmaceutical companies.

One of the world’s largest pharmaceutical players, Takeda Pharmaceutical Co...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

  • 52 weekly issues
  • Subscriber-only digital content every business day, plus full access to archives
  • Book of Lists — the most comprehensive business resource in San Diego
  • San Diego 500 — influential business leaders you need to know
Yours for only $99